Effectiveness of recombinant human erythropoietin, vitamin D3 and iron therapy on long-term survival of patients with end-stage renal disease receiving haemodialysis: Analysis of 702 patients after 10-year follow-up

Public Health Nutrition

Volumn 12, Issue 12, 2009, Pages 2410-2415

  Chang, Huan Cheng ^a,b   Chen, Chien Lung ^b   Chiu, Te Li ^b   Chen, Shu I ^b   Yen, Amy Ming Fang ^c   Chen, Tony Hsiu Hsi ^c  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b LI SHIN HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

End stage renal disease; Haemodialysis; Recombinant human erythropoietin; Survival

Indexed keywords

COLECALCIFEROL; ERYTHROPOIETIN; IRON; RECOMBINANT PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CHRONIC KIDNEY FAILURE; COHORT ANALYSIS; DIET SUPPLEMENTATION; FEMALE; FOLLOW UP; HUMAN; INFANT; KAPLAN MEIER METHOD; MALE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; NEWBORN; PRESCHOOL CHILD; PROGNOSIS; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; CHOLECALCIFEROL; COHORT STUDIES; DIETARY SUPPLEMENTS; ERYTHROPOIETIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INFANT, NEWBORN; IRON; KAPLAN-MEIERS ESTIMATE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; RECOMBINANT PROTEINS; RENAL DIALYSIS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 74949106869     PISSN: 13689800     EISSN: 14752727     Source Type: Journal    
DOI: 10.1017/S1368980009005308     Document Type: Article

References (17)

1. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (2002) USRDS 2002 Annual Data Report: Atlas of End-Stage Renal Disease in the United States, pp. 205-212. Bethesda, MD: NIH.
2. Van Wyck DB (1989) Iron management during recombinant human erythropoietin therapy. Am J Kidney Dis 14, 9-13.
3. Tamg DC, Chen TW & Huang TP (1995) Iron metabolism indices for early prediction of the response hemodialysis patients. Am J Nephrol 15, 230-237.
4. Kleiner MJ, Van Wyck DB, Kaupke CJ & Kirlin LF (1995) The role of iron and other factors in patients unresponsive to erythropoietin therapy. Semin Dial 8, 29-34.
5. Silverberg DS, Blum M, Peer G, Kaplan E & Aiana A (1996) Intravenous ferric saccharate as an iron supplement in dialysis patients. Nephron 72, 413-417.
6. Ebert BL & Bunn HF (1999) Regulation of erythropoietin gene. Blood 94, 1864-1877.
7. Charytan C, Levin N, Al-Saloum M, Hafeez T, Gagnon S & Van Wyck DB (2001) Efficacy and safety of iron sucrose for iron deficiency in patients with dialysis-associated anaemia: North American clinical trial. Am J Kidney Dis 37, 300-307.
8. Nissenson AR, Lindsay RM, Swan S, Seligman P & Strobos J (1999) Sodium ferric gluconate complex in sucrose is safe and effective in hemodialysis patients: North American clinical trial. Am J Kidney Dis 33, 471-482.
9. National Kidney Foundation (2001) K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease, 2000. Am J Kidney Dis 37, S182-S238.
10. Van Wyck DB, Cavallo G, Spinowitz B S, Adhikarla R, Gagnon S, Charytan C & Levin N (2000) Safety and efficacy of iron sucrose in patients sensitive to iron dextran. Am J Kidney Dis 36, 88-97.
11. Kalantar-Zadeh K, McAllister CJ, Lehn RS, Liu E & Kopple JD (2004) A low serum iron level is a predictor of poor outcome in hemodialysis patients. Am J Kidney Dis 43, 671-684.
12. Macdougall IC, Chandler G, Elston O & Harchowal J (1999) Beneficial effects of adopting an aggressive intravenous iron policy in a hemodialysis unit. Am J Kidney Dis 34, S40-S46.
13. Silva J, Andrade S, Ventura H, Santos JP, Colaco S, Oliveira C & Ponce P (1998) Iron supplementation in hemodialysis- practical clinical guideline. NTD 13, 2572-2577.
14. Besarab A, Frinak S & Yee J (1999) An indistinct balance: the safety and efficacy of parenteral iron therapy. J Am Soc Nephrol 10, 2029-2043.
15. Aronoff GR, Bennett WM, Blumenthal S et al. (2004) Iron sucrose in hemodialysis patients: safety of replacement and maintenance regimens. Kidney Int 66, 1193-1198.
16. Fishbane S (2003) Safety in iron management. Am J Kidney Dis 41, 18-26.
17. Yee J & Besarab A (2002) Iron sucrose: the oldest iron therapy becomes new. Am J Kidney Dis 40, 1111-1121.